Table 4.
Estimated annual number of diagnostic evaluations and treatment for precancerous lesions and related costs by age group, Australia 2010
| Age group (years) |
Diagnostic procedures for precancerous lesions |
Treatment for precancerous lesions and post-treatment follow-up |
Colposcopy to treatment ratio |
|||||
|---|---|---|---|---|---|---|---|---|
| No. of colposcopy evaluations†,†† | No. of histological evaluations†,†† | Related cost | % total | No. of precancerous lesion treatments†,‡ | Related cost | % total | ||
|
18-20 |
700 |
400 |
$0.2 M |
1% |
200 |
$0.3 M |
1% |
3.2 |
|
20-24 |
10,900 |
5,900 |
$3.0 M |
14% |
3,300 |
$5.2 M |
11% |
3.3 |
|
25-29 |
10,500 |
5,700 |
$2.9 M |
14% |
3,000 |
$5.5 M |
12% |
3.5 |
|
30-49 |
33,900 |
16,900 |
$10.2 M |
48% |
7,800 |
$20.1 M |
44% |
4.3 |
|
50-69 |
13,500 |
4,800 |
$4.4 M |
21% |
4,100 |
$12.8 M |
28% |
3.3 |
|
70+‡‡ |
1,400 |
500 |
$0.5 M |
2% |
400 |
$1.6 M |
3% |
3.1 |
|
20-69 |
68,800 |
33,200 |
$20.5 M |
97% |
18,200 |
$43.6 M |
96% |
3.8 |
| 0-84 | 70,900 | 34,100 | $21.2 M | 100% | 18,900 | $45.5 M | 100% | 3.8 |
† Rounded to the nearest 100.
††Multiple biopsies taken at the same colposcopy were not included.
‡ Includes procedures performed in women without prior confirmation of high-grade disease (e.g. women with unsatisfactory colposcopy findings) who may have been found to have a low-grade histological outcome.
‡‡ Up to 84 years.